ATTO · Attovia Therapeutics, Inc. · Documents
Market Cap
$631.36M
Shares
45.65M
Volume · Oct 23
330.73K
Avg daily vol (57 sessions)
446.02K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-16 | 2026-09-30 | |
| 10-Q | — | 2026-09-02 | 2026-06-30 | |
| 8-K | — | 2026-09-02 | — | |
| 8-K | — | 2026-08-06 | — | |
| S-1/A | — | 2026-08-04 | — | |
| S-1/A | — | 2026-07-29 | — | |
| S-1 | — | 2026-07-14 | — |
Showing 1–7 of 7 filings